NXLIW Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 jun 2024 @ 18:15):
Our systems believe the stock currently is undervalued by 0.27% compare to its pairs and should correct upwards.

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China...

Stats
Dagens volum	50 009
Gjennomsnittsvolum	0
Markedsverdi	2.48M
EPS	$-0.140 ( Q1 \| 2024-05-10 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 43.86
ATR14	$0.0290 (8.79%)

ABMD 0.00%

AMIX -2.65%

BBLGW -19.30%

BVS 0.55%

COCH 0.43%

DHAI -3.78%

DHAIW 0.00%

DNAY 8.33%

EYES -5.05%

GBS -1.58%

HSCS -2.26%

HSCSW 19.64%

IINNW -27.42%

INVO -6.67%

LFWD 0.49%

MDAI 1.82%

MGRM -2.86%

MXCT -2.57%

NVNOW -32.98%

NXL 25.67%

NXLIW -25.00%

OSA -7.35%

OSAAW -6.40%

PAVMW 105.67%

PAVMZ -4.76%

PETVW 0.00%

QTI 1.57%

QTNT 0.00%

Insider Trading

Date	Person	Action	Amount	type
2022-09-16	White Mark	Buy	25 000	Common stock warrants
2022-09-16	Owens David	Buy	2 500	Common stock warrants
2022-09-16	Kazden Alan	Buy	2 500	Common stock warrants
2022-09-28	Elson Marilyn	Buy	9 500	Common stock warrants
2022-09-16	Morad Rick	Buy	2 500	Common Stock

INSIDER POWER
100.00
Last 17 transactions
Buy: 250 000 \| Sell: 0

Korrelasjon (AI algo v.1.1b): Undervalued: 0.27% $0.331 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Nexalin Technology, Inc. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Nexalin Technology, Inc. Økonomi

Annual	2023
Omsetning:	$110 748
Bruttogevinst:	$-1.30M (-1 176.41 %)
EPS:	$-0.630

FY	2023
Omsetning:	$110 748
Bruttogevinst:	$-1.30M (-1 176.41 %)
EPS:	$-0.630

FY	2022
Omsetning:	$1.32M
Bruttogevinst:	$958 145 (72.51 %)
EPS:	$-0.260

Financial Reports:

No articles found.

Nexalin Technology, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Nexalin Technology, Inc.

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company\'s Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer\'s disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.